SCHEMBL9097002

SCHEMBL9097002

COC(=O)CNC(=O)c1[c]c(=O)[nH]cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.44
▸ GAA P10253 1/20 0.44
▸ SMN1; SMN2 Q16637 3/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ TSHR P16473 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ MAPK1 P28482 1/20 0.42
▸ CYP1A2 P05177 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ ALOX5 P09917 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ STAMBP O95630 1/20 0.36
▸ TET2 Q6N021 1/20 0.35
▸ VEGFA P15692 2/20 0.34
▸ FLT1 P17948 2/20 0.34
▸ EGLN1 Q9GZT9 2/20 0.34
▸ EGLN3 Q9H6Z9 2/20 0.34
▸ RECQL P46063 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9097570 0.71 KDM4E (0.43) KDM4EGAASMN1; SMN2MEN1TSHR
SCHEMBL8947242 0.68 KMT2A (0.67) KDM4EGAASMN1; SMN2MEN1TSHR
SCHEMBL9096747 0.68 KDM4E (0.41) KDM4EGAASMN1; SMN2MEN1TSHR
SCHEMBL16670962 0.67 PDPK1 (0.39) KDM4ETSHRKMT2AHSD17B10MAPK1
SCHEMBL24224262 0.66 KMT2A (0.59) KDM4EGAASMN1; SMN2MEN1TSHR
SCHEMBL1154292 0.65 AXL (0.47) SMN1; SMN2MEN1KMT2AALDH1A1VEGFA
SCHEMBL15595417 0.65 KDM4E (0.70) KDM4EGAASMN1; SMN2MEN1TSHR
SCHEMBL4510115 0.65 KDM4E (0.56) KDM4EGAASMN1; SMN2MEN1TSHR
SCHEMBL9099272 0.65 KDM4E (0.43) KDM4EGAASMN1; SMN2MEN1TSHR
SCHEMBL9097874 0.65 KDM4E (0.44) KDM4EGAASMN1; SMN2MEN1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0323441-B1 5-Fluorouracil derivatives OTSUKA PHARMA CO LTD (JP) 1996-04-24 — — EP disclosed
EP-0436902-B1 5-Fluorouracil derivatives OTSUKA PHARMA CO LTD (JP) 1995-06-28 — — EP disclosed
EP-0247381-B1 5-FLUROROURACIL DERIVATIVES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1993-08-04 — — EP disclosed
US-5047521-A Anticarcinogenic agents OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1991-09-10 — — US disclosed
EP-0436902-A1 5-Fluorouracil derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1991-07-17 — — EP disclosed
US-4983609-A Anticancer agents OTSUKA PHARMACEUTICAL (JP) 1991-01-08 — — US disclosed
US-4864021-A ANTICARCINOGENIC AGENTS, ANTITUMOR AGENTS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1989-09-05 — — US disclosed
EP-0323441-A2 5-Fluorouracil derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1989-07-05 — — EP disclosed
EP-0247381-A2 5-flurorouracil derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1987-12-02 — — EP disclosed
EP-0180897-A2 5-Fluorouracil derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1986-05-14 — — EP disclosed
Send feedback